James Leal - Dec 27, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
SVP, Operations
Signature
s/ David B. Berger, Attorney-in-Fact for James A. Leal
Stock symbol
TNDM
Transactions as of
Dec 27, 2021
Transactions value $
-$77,606
Form type
4
Date filed
12/29/2021, 03:29 PM
Previous filing
Dec 1, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $85.9K +1.67K +41.59% $51.50 5.68K Dec 27, 2021 Direct F1
transaction TNDM Common Stock Options Exercise $19.7K +239 +4.21% $82.34 5.91K Dec 27, 2021 Direct F1
transaction TNDM Common Stock Sale -$81.5K -540 -9.13% $150.95* 5.37K Dec 27, 2021 Direct F2, F3
transaction TNDM Common Stock Sale -$192K -1.27K -23.56% $151.60* 4.11K Dec 27, 2021 Direct F2, F4
transaction TNDM Common Stock Sale -$15.2K -100 -2.43% $152.27* 4.01K Dec 27, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $85.9K +1.67K +7.69% $51.50 23.3K Dec 27, 2021 Common Stock 1.67K $51.50 Direct F5, F6
transaction TNDM Stock Option Options Exercise $19.7K +239 +3.58% $82.34 6.91K Dec 27, 2021 Common Stock 239 $82.34 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
F3 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.25 to $151.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F4 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $151.26 to $152.09.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F5 The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F6 The expiration date for these options is 10 years from the date of grant.
F7 The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.